Open Access

Isoforskolin downregulates proinflammatory responses induced by Borrelia burgdorferi basic membrane protein A

  • Authors:
    • Hua Zhao
    • Aihua Liu
    • Longqiang Shen
    • Cuiping Xu
    • Ziwei Zhu
    • Jiaru Yang
    • Xinling Han
    • Fukai Bao
    • Weimin Yang
  • View Affiliations

  • Published online on: October 13, 2017     https://doi.org/10.3892/etm.2017.5300
  • Pages: 5974-5980
  • Copyright: © Zhao et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The plant Coleus forskohlii is distributed primarily in India, Thailand, China, Egypt and Brazil and has a history of use in the treatment of multiple diseases. Isoforskolin (ISOF) is the principle active component of C. forskohlii native to China and has previously been studied for its biological effects. The aim of the present study was to evaluate the effect of ISOF on the proinflammatory responses induced by recombinant Borrelia burgdorferi basic membrane protein A (rBmpA). In in vitro experiments, the proinflammatory effects of rBmpA and the anti‑inflammatory function of ISOF were evaluated in murine macrophages, human macrophages and dendritic cells by detecting the transcription and expression of tumor necrosis factor (TNF)‑α and interleukin (IL)‑6. In in vivo experiments, mean arthritis index and X‑ray and histopathological examinations were used to verify the role of ISOF in experimental Lyme arthritis in mice. The results indicated that rBmpA, which induced the transcription and expression of TNF‑α and IL‑6, activated proinflammatory responses in murine macrophages, human macrophages and dendritic cells. In turn, ISOF downregulated the transcription and expression of TNF‑α and IL‑6 induced by rBmpA. Additionally, the in vivo experiments demonstrated that ISOF could also inhibit the symptoms of experimental Lyme arthritis. These results suggest that ISOF may have a potential application as an anti‑inflammatory agent for the treatment of Lyme arthritis.
View Figures
View References

Related Articles

Journal Cover

December-2017
Volume 14 Issue 6

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Zhao H, Liu A, Shen L, Xu C, Zhu Z, Yang J, Han X, Bao F and Yang W: Isoforskolin downregulates proinflammatory responses induced by Borrelia burgdorferi basic membrane protein A. Exp Ther Med 14: 5974-5980, 2017
APA
Zhao, H., Liu, A., Shen, L., Xu, C., Zhu, Z., Yang, J. ... Yang, W. (2017). Isoforskolin downregulates proinflammatory responses induced by Borrelia burgdorferi basic membrane protein A. Experimental and Therapeutic Medicine, 14, 5974-5980. https://doi.org/10.3892/etm.2017.5300
MLA
Zhao, H., Liu, A., Shen, L., Xu, C., Zhu, Z., Yang, J., Han, X., Bao, F., Yang, W."Isoforskolin downregulates proinflammatory responses induced by Borrelia burgdorferi basic membrane protein A". Experimental and Therapeutic Medicine 14.6 (2017): 5974-5980.
Chicago
Zhao, H., Liu, A., Shen, L., Xu, C., Zhu, Z., Yang, J., Han, X., Bao, F., Yang, W."Isoforskolin downregulates proinflammatory responses induced by Borrelia burgdorferi basic membrane protein A". Experimental and Therapeutic Medicine 14, no. 6 (2017): 5974-5980. https://doi.org/10.3892/etm.2017.5300